This article has been updated from an earlier version to include a correction from Ariadne Genomics regarding the NIH institute that provided the funding.
NEW YORK, Oct. 6 (GenomeWeb News) - Ariadne Genomics has won a $750,000 Phase II SBIR grant from the National Institutes of Health, the Rockville, Md.-based company said today.
The company plans to use the two-year grant, from the National Center for Research Resources, to develop new software products based on MedScan, its natural language processing technology.
The new software will be centered around identification of semantic links that describe functional relations among biological entities. Ariadne plans to make it available as a desktop or client-server application that will work with publicly available text sources as well as users' document collections.